Literature DB >> 8181029

The complement system in myocardial ischaemia/reperfusion injury.

K S Kilgore1, G S Friedrichs, J W Homeister, B R Lucchesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8181029     DOI： 10.1093/cvr/28.4.437

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  23 in total

1.  Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation.

Authors:  C Mold; C A Morris
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin.

Authors:  Chandrika Mulakala; John D Lambris; Yiannis Kaznessis
Journal:  Bioorg Med Chem       Date:  2006-12-13       Impact factor: 3.641

4.  PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment.

Authors:  T Arnould; R Thibaut-Vercruyssen; N Bouaziz; M Dieu; J Remacle; C Michiels
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Complement and contact system activation in acute congestive heart failure patients.

Authors:  C Suffritti; E Tobaldini; R Schiavon; S Strada; L Maggioni; S Mehta; G Sandrone; E Toschi-Dias; M Cicardi; N Montano
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

6.  Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.

Authors:  Esther Sok Hwee Cheow; Woo Chin Cheng; Chuen Neng Lee; Dominique de Kleijn; Vitaly Sorokin; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2016-05-27       Impact factor: 5.911

7.  Ischemia/reperfusion injury: The role of immune cells.

Authors:  Mozow Y Zuidema; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-10-26

8.  Solution structure of Compstatin, a potent complement inhibitor.

Authors:  D Morikis; N Assa-Munt; A Sahu; J D Lambris
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

9.  Targeting of functional antibody-CD59 fusion proteins to a cell surface.

Authors:  H F Zhang; J Yu; E Bajwa; S L Morrison; S Tomlinson
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.

Authors:  Kwang-Seok Oh; Mee-Hyang Kweon; Ki-Hyeong Rhee; Keyong Ho Lee; Ha-Chin Sung
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.